Comparison of the prevalence of advanced fibrosis (AF) using two combinations: Liver stiffness measurement (LSM or VCTE Fibroscan) along with LIVERSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort

AI-based blood tests LIVERSTAT for advanced fibrosis (AF) in patients with T2D can streamline the diagnostic process.

Aim of this study is to retrospectively evaluate two combinations, LIVERSTAT & Liver Stiffness measurement (LSM) and FIB-4 & LSM, in identifying presumed advanced fibrosis among pts with T2D and MASLD.

Comparison of the prevalence of advanced fibrosis (AF) using two combinations: Liver stiffness measurement (LSM or VCTE Fibroscan) along with LIVERSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort

Comparison of the prevalence of advanced fibrosis (AF) using two combinations: Liver stiffness measurement (LSM or VCTE Fibroscan) along with LIVERSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort

US Headquarters

Asia Headquarters

For Clinicians

For Patients

Our Technology

About Us

Resources

Let’s Keep in Touch!